A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

NCT00879034 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Progeria
Hutchinson-Gilford Syndrome

Interventions

DRUG: Lonafarnib
DRUG: Zoledronic Acid
DRUG: Pravastatin

Sponsor

Boston Children's Hospital

Collaborators

[object Object]
[object Object]
[object Object]